Recommendations for Cervical Cancer Prevention in Central and Eastern Europe and Central Asia

Vaccine

Volumn 31, Issue S7, 2013, Pages

  Poljak, Mario ^a   Rogovskaya, Svetlana I ^b   Kesić, Vesna ^c   Bray, Freddie ^d   Berkhof, Johannes ^e   Seme, Katja ^a   Brotons, Maria ^f   Castellsagué, Xavier ^f,g   Syrjänen, Stina ^h   Arbyn, Marc ^i,j   Bosch, F Xavier ^f  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Russian Medical Academy of Postgraduate Education   (Russian Federation)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^h UNIVERSITY OF TURKU   (Finland)

ⁱ SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^j UNIVERSITY OF ANTWERP   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ASIA; CANCER PREVENTION; COST EFFECTIVENESS ANALYSIS; EASTERN EUROPE; ENDOMETRIUM CYTOLOGY; NOTE; PRIORITY JOURNAL; SCREENING; SECONDARY PREVENTION; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

ASIA, CENTRAL; EARLY DETECTION OF CANCER; EUROPE, EASTERN; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84890226337     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.038     Document Type: Note

References (10)

1. Kesic V. Prevention of Cervical Cancer in Central and Eastern Europe and Central Asia: A Challenge for the Future. Vaccine 2013, 31S:vii-ix.
2. Bray F., Lortet-Tieulent J., Znaor A., Brotons M., Poljak M., Arbyn M. Patterns and Trends in Human Papillomavirus-Related Diseases in Central and Eastern Europe and Central Asia. Vaccine 2013, 31S:H32-H45.
3. Rogovskaya S.I., Shabalova I.P., Mikheeva I.V., Minkina G.N., Podzolkova N.M., Shipulina O.Y., et al. Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Russian Federation, the Western Countries of the Former Soviet Union, Caucasus Region and Central Asia. Vaccine 2013, 31S:H46-H58.
4. Poljak M., Seme K., Maver P.J., Kocjan B.J., Cuschieri K.S., Rogovskaya S.I., et al. Human Papillomavirus Prevalence and Type-distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Central and Eastern Europe. Vaccine 2013, 31S:H59-H70.
5. Berkhof H., Bogaards J.A., Demirel E., Diaz M., Sharma M., Kim J.J. Cost-effectiveness of Cervical Cancer Prevention in Central and Eastern Europe and Central Asia. Vaccine 2013, 31S:H71-H79.
6. Arbyn M., Castellsague X., de Sanjose S., Bruni L., Saraiya M., Bray F., et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011, 22:2675-2686.
7. Arbyn M., Anttila A., Jordan J., Ronco G., Schenck U., Segnan N., et al. European Guidelines for Quality Assurance in Cervical Cancer Screening Second edition - summary document. Ann Oncol 2010, 21:448-458.
8. Arbyn M., Ronco G., Anttila A., Meijer C.J.L.M., Poljak M., Ogilvie G., et al. Evidence regarding HPV testing in secondary prevention of cervical cancer. Vaccine 2012, 30(Suppl 5):F88-F99.
9. de Kok I.M., van Rosmalen J., Dillner J., Arbyn M., Sasieni P., Iftner T., et al. Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model. Br Med J 2012, 344:e670.
10. Poljak M., Cuzick J., Kocjan B.J., Iftner T., Dillner J., Arbyn M. Nucleic acid tests for the detection of alpha human papillomaviruses. Vaccine 2012, 30(Suppl 5):F100-F106.